Boston, MA, January 27, 2012 -- Cambridge, MA based biological reagents provider NovaTeinBio has recently announced that have added to the company’s exceptional selection of ELISA kit products. The company has made this move in order to continue to provide one of North America’s largest selections of ELISA kit solutions to their clientele across the country and around the world.

The new selections available within the NovaTeinBio catalog will improve upon their clients’ abilities to speed up their testing protocols as well as delve into new avenues of research that could offer outstanding potential for community-wide reward in the long term. Consider for example the company’s new Acylation Stimulating Protein (ASP) ELISA kit,which is a testing solutions designed to provide pharmaceutical companies that are researching potential weight-loss treatments with the ability to hone in on specific cell actions. ASP has been found in higher levels in patients with obesity related diseases such as type 2 diabetes. In addition, it has been found that dysfunction of the ASP pathway is correlated with a higher incidence of coronary artery disease, which means that this outstanding ELISA kit could be of great use for a broad range of in-house researching needs.

As research companies around the globe look to find ways to enhance not only the speed of their testing but also the scope, they will come to depend on biological reagent providers such as NovaTeinBio to provide them with the tools to match their objectives. With the recent addition of new ELISA kits to the company catalog, NovaTeinBio is once again provide to be a high value partner to some of the medical research industry’s leading innovators.

Please contact the team at NovaTeinBio today for more details on the recent products added to the company catalog.